KPF
EIDX

K2 Principal Fund’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

K2 Principal Fund’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,093
Closed -$3.96M – 433
2020
Q4 		$3.96M Buy
+30,093
New +$3.96M 0.35% 52